Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Blood vessels engineered from human cells.

Zhaodi Gong1, Laura E Niklason

  • 1Department of Anesthesia, Duke University, Durham, NC 27708, USA.

Trends in Cardiovascular Medicine
|June 20, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering function in lung biology: integrating imaging, regenerative constructs, and functional biodesign.

American journal of physiology. Lung cellular and molecular physiology·2026
Same author

Vascular Endothelial Growth Factor-D Improves Lung Vascular Integrity During Acute Lung Injury.

Circulation research·2026
Same author

Reply: Model Choice and Interpretation in Coronary Tissue Engineering: Still More Questions Than Answers.

JACC. Basic to translational science·2026
Same author

Long-term safety and efficacy outcomes of the Acellular Tissue Engineered Vessel (ATEV) in extremity arterial trauma repair.

Journal of vascular surgery cases and innovative techniques·2025
Same author

Short-term performance of Symvess (acellular tissue engineered vessel-tyod) compared to external control data for autologous vein in treatment of extremity arterial injury.

Trauma surgery & acute care open·2025
Same author

Bioengineered human blood vessels to treat hospital-acquired vascular complications.

Journal of vascular surgery cases and innovative techniques·2025
Same journal

Comment on "advancing personalised care in atrial fibrillation and stroke: The potential impact of AI from prevention to rehabilitation".

Trends in cardiovascular medicine·2026
Same journal

Response to: Comment on "Advancing personalised care in atrial fibrillation and stroke: The potential impact of AI from prevention to rehabilitation" (TCM-D-26-00198).

Trends in cardiovascular medicine·2026
Same journal

High-sensitivity C-reactive protein as a prognostic biomarker in cardiovascular diseases: implications for atherosclerosis, chronic kidney disease, and heart failure - a review.

Trends in cardiovascular medicine·2026
Same journal

The cost of false dichotomies in a dynamic disease.

Trends in cardiovascular medicine·2026
Same journal

Late-presenting ST-segment elevation myocardial infarction: is it just a matter of time? From temporal cutoffs to biological staging.

Trends in cardiovascular medicine·2026
Same journal

Targeting rotors in ventricular fibrillation: Molecular mechanisms and future therapeutic strategies.

Trends in cardiovascular medicine·2026
See all related articles

Human vascular tissue engineering shows progress, but challenges remain in scaffold and cell source selection for arterial regeneration. Despite limitations, several engineered vascular strategies have advanced to clinical trials.

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Vascular Biology

Background:

  • Human vascular tissue engineering has advanced significantly in the last decade.
  • Key challenges include identifying optimal culture scaffolds and cell sources for arterial regeneration.
  • The limited replicative lifespan of adult human cells compared to animal cells presents a significant hurdle.

Purpose of the Study:

  • To review the progress and persistent challenges in human vascular tissue engineering.
  • To highlight strategies for generating replacement vessels for arterial regeneration.
  • To discuss the implications of cellular limitations on tissue engineering outcomes.

Main Methods:

  • Literature review of recent advancements in vascular tissue engineering.

Related Experiment Videos

  • Analysis of different scaffold materials and cell sources used in arterial regeneration.
  • Evaluation of strategies that have reached clinical trials.

    • Main Results:

    • Substantial progress has been made in developing engineered vascular tissues.
    • Optimal culture scaffolds and cell sources for arterial regeneration are still under investigation.
    • Several engineered vascular strategies have successfully progressed into clinical trials.

    Conclusions:

    • Human vascular tissue engineering is a rapidly advancing field with significant clinical potential.
    • Overcoming cellular limitations and optimizing scaffold/cell source combinations are crucial for future success.
    • The progression to clinical trials indicates the viability of current engineered vascular strategies.